Understanding treatment effects for people with both opioid and stimulant use disorders
Transporting treatment effects from clinical trials to real-world populations with co-occurring opioid and stimulant use disorders
This study is looking at how well different treatments for substance use disorders, especially for people using opioids and stimulants, can work for everyday folks, so we can make them more effective for everyone who needs help.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10873983 on NIH RePORTER |
What this research studies
This research investigates how effective treatments for substance use disorders (SUDs), particularly those involving opioids and stimulants, can be adapted for real-world populations. It aims to bridge the gap between clinical trial results and the diverse individuals who actually need these treatments. By utilizing advanced data science techniques, the study will analyze how treatment outcomes might differ in patients who use multiple substances compared to those in clinical trials. This approach seeks to provide insights that can improve treatment effectiveness for a broader range of patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults over 21 years old who are experiencing co-occurring opioid and stimulant use disorders.
Not a fit: Patients who are only dealing with a single substance use disorder, either opioid or stimulant, may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies for individuals struggling with both opioid and stimulant use disorders.
How similar studies have performed: While there has been significant research on individual substance use disorders, this approach to understanding treatment effects in polysubstance users is relatively novel and has not been extensively tested.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Cook, Ryan — Oregon Health & Science University
- Study coordinator: Cook, Ryan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.